Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Calcitriol
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Weill Cornell Medical College in Qatar
Deal Size : Inapplicable
Deal Type : Inapplicable
An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 13, 2017
Lead Product(s) : Calcitriol
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Weill Cornell Medical College in Qatar
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcitriol
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Plaque Psoriasis Study in Pediatric Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 10, 2014
Lead Product(s) : Calcitriol
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcitriol
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 29, 2014
Lead Product(s) : Calcitriol
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcitriol
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 11, 2013
Lead Product(s) : Calcitriol
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcitriol
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 01, 2012
Lead Product(s) : Calcitriol
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcitriol
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Galderma
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Evaluate Vectical in Combination With Clobex Spray to Treatment Plaque Psoriasis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 21, 2010
Lead Product(s) : Calcitriol
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Galderma
Deal Size : Inapplicable
Deal Type : Inapplicable